Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Simultaneous Administration of Respiratory Syncytial Virus (RSV) Preventive Monoclonal Antibody With Routine Childhood Immunizations in Infants

NCT07158814 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT07158814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07158814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Simultaneous Administration of Respiratory Syncytial Virus (RSV) Preventive Monoclonal Antibody With Routine Childhood Immunizations in Infants
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Recruiting
Start date
October 2, 2025
Completion date
April 30, 2027
Enrollment
524 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

adverse event following immunisation, fever